Machine learning-based prediction model for 28-day mortality in acute kidney injury patients with liver cirrhosis: A MIMIC-IV database analysis

基于机器学习的急性肾损伤合并肝硬化患者28天死亡率预测模型:MIMIC-IV数据库分析

阅读:1

Abstract

BACKGROUND: Acute kidney injury (AKI) in patients with liver cirrhosis represents a significant clinical challenge with high mortality rates. This study aimed to develop and validate a machine learning-based prediction model for 28-day mortality in AKI patients with liver cirrhosis using the MIMIC-IV database. METHODS: This retrospective study analyzed data from 4,168 AKI patients, including 601 with concurrent liver cirrhosis, from the MIMIC-IV database. Patient selection followed strict inclusion and exclusion criteria. The study implemented comprehensive data preprocessing, including feature normalization and selection through Recursive Feature Elimination. Multiple machine learning algorithms were evaluated, with model performance assessed through ROC curves, calibration curves, and precision-recall analysis. SHAP analysis was conducted to interpret feature contributions to mortality prediction. RESULTS: The liver cirrhosis group demonstrated distinct clinical characteristics, including significantly lower age (median 60 vs 70 years, p < 0.001) and higher disease severity scores (SOFA 11 vs 8 points) compared to non-cirrhotic patients. Survival analysis confirmed significantly lower 28-day survival probability in the cirrhosis group (Log-rank test, χ2 = 46.5, p < 0.001). The Random Forest model achieved optimal performance with an AUC of 0.85 and precision-recall area of 0.81. SHAP analysis identified pH, anion gap, and total CO2 as the most significant predictive factors, with notable interaction effects among these indicators. CONCLUSION: This study successfully developed a machine learning model for predicting 28-day mortality in AKI patients with liver cirrhosis. The model demonstrated superior clinical decision-making value compared to traditional scoring systems, particularly in moderate-risk threshold intervals. The findings emphasize the crucial role of acid-base balance indicators in mortality risk assessment, providing valuable insights for clinical intervention strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。